Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon

Travel Medicine and Infectious Disease

Volumn 6, Issue 3, 2008, Pages 128-129

  Gallien, Sébastien ^a   Taieb, Fabien ^a   Schlemmer, Frédéric ^a   Lagrange Xelot, Marie ^a   Atlan, Alexandra ^a   Sarfati, Claudine ^a   Molina, Jean Michel ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Chemoprophylaxis; Malaria; Malarone; Pharmacology; Plasmodium ovale; Travel

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DIETHYLTOLUAMIDE; HYDROXYCHLOROQUINE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BED NET; CAMEROON; CASE REPORT; CHEMOPROPHYLAXIS; DISEASE DURATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; FEVER; HEADACHE; HOSPITAL ADMISSION; HUMAN; INSECT CONTROL; MALARIA; MALARIA CONTROL; MALE; PATIENT COMPLIANCE; PLASMODIUM OVALE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; SCHIZONT; SYMPTOM; TRAVEL; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANIMALS; ANTIMALARIALS; ATOVAQUONE; CAMEROON; CHLOROGUANIDE; DIAGNOSIS, DIFFERENTIAL; FEVER; FRANCE; HEADACHE; HUMANS; MALARIA; MALE; PLASMODIUM OVALE; TRAVEL;

EID: 43249127195     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2008.01.011     Document Type: Article

References (10)

1. Collins W.E., and Jeffery G.M. Plasmodium ovale: parasite and disease. Clin Microbiol Rev 18 (2005) 570-581
2. WHO. Guidelines for the treatment of malaria (2006), WHO, Geneva p. 1-253
3. Boggild A.K., Parise M.E., Lewis L.S., and Kain K.C. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg 76 (2007) 208-223
4. Schwartz E., Parise M., Kozarsky P., and Cetron M. Delayed onset of malaria-implications for chemoprophylaxis in travelers. N Engl J Med 349 (2003) 1510-1516
5. Kain K.C. Atovaquone/proguanil: the need for family protection. J Travel Med 10 Suppl. 1 (2003) S8-S12
6. Jimenez B.C., Navarro M., Huerga H., Lopez-Roman E., Mendoza A., and Lopez-Velez R. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis. J Travel Med 13 (2006) 373-375
7. Kofoed K., and Petersen E. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. J Travel Med 10 (2003) 150-154
8. Hogh B., Clarke P.D., Camus D., Nothdurft H.D., Overbosch D., Gunther M., et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Lancet 356 (2000) 1888-1894
9. Povinelli L., Monson T.A., Fox B.C., Parise M.E., Morrisey J.M., and Vaidya A.B. Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis. J Travel Med 10 (2003) 353-355
10. Wichmann O., Muehlberger N., Jelinek T., Alifrangis M., Peyerl-Hoffmann G., Muhlen M., et al. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis 190 (2004) 1541-1546